179 related articles for article (PubMed ID: 2943354)
1. Peripheral 5-HT2-like receptors. Can they be classified with the available antagonists?
Leff P; Martin GR
Br J Pharmacol; 1986 Jul; 88(3):585-93. PubMed ID: 2943354
[TBL] [Abstract][Full Text] [Related]
2. The classification of peripheral 5-HT2-like receptors using tryptamine agonist and antagonist analogues.
Leff P; Martin GR; Morse JM
Br J Pharmacol; 1986 Nov; 89(3):493-9. PubMed ID: 3801784
[TBL] [Abstract][Full Text] [Related]
3. A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists.
Feniuk W; Humphrey PP; Perren MJ; Watts AD
Br J Pharmacol; 1985 Nov; 86(3):697-704. PubMed ID: 2933110
[TBL] [Abstract][Full Text] [Related]
4. Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by use of tryptamine analogues.
Leff P; Martin GR; Morse JM
Br J Pharmacol; 1987 Jun; 91(2):321-31. PubMed ID: 3607360
[TBL] [Abstract][Full Text] [Related]
5. Allosteric properties of the 5-HT2 receptor system of the rat tail artery. Ritanserin and methysergide are not competitive 5-HT2 receptor antagonists but allosteric modulators.
Frenken M; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):359-66. PubMed ID: 3110629
[TBL] [Abstract][Full Text] [Related]
6. Involvement of 5-HT1B receptors in collar-induced hypersensitivity to 5-hydroxytryptamine of the rabbit carotid artery.
Geerts IS; Matthys KE; Herman AG; Bult H
Br J Pharmacol; 1999 Jul; 127(6):1327-36. PubMed ID: 10455282
[TBL] [Abstract][Full Text] [Related]
7. A paradox: the 5-HT2-receptor antagonist ketanserin restores the 5-HT-induced contraction depressed by methysergide in large coronary arteries of calf. Allosteric regulation of 5-HT2-receptors.
Kaumann AJ; Frenken M
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):295-300. PubMed ID: 3157064
[TBL] [Abstract][Full Text] [Related]
8. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
Cohen ML; Schenck KW; Kurz KD
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
[TBL] [Abstract][Full Text] [Related]
9. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
Lucki I; Nobler MS; Frazer A
J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097
[TBL] [Abstract][Full Text] [Related]
10. Actions of non-peptide ergot alkaloids at 5-HT1-like and 5-HT2 receptors mediating vascular smooth muscle contraction.
MacLennan SJ; Martin GR
Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):120-9. PubMed ID: 2234096
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two different arterial tissues suggests possible 5-hydroxytryptamine2 receptor heterogeneity.
Killam AL; Nikam SS; Lambert GM; Martin AR; Nelson DL
J Pharmacol Exp Ther; 1990 Mar; 252(3):1083-9. PubMed ID: 2319460
[TBL] [Abstract][Full Text] [Related]
12. Allosteric properties of 5-HT2 receptors in tracheal smooth muscle.
Lemoine H; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):91-7. PubMed ID: 2944004
[TBL] [Abstract][Full Text] [Related]
13. Functional 5-HT receptor subtypes in the isolated canine common carotid artery.
Vhora S; Chiba S
Heart Vessels; 1994; 9(5):235-40. PubMed ID: 7814300
[TBL] [Abstract][Full Text] [Related]
14. The effects of serotonin antagonists in a behavioral despair procedure in mice.
Luttinger D; Freedman M; Hamel L; Ward SJ; Perrone M
Eur J Pharmacol; 1984 Dec; 107(1):53-8. PubMed ID: 6526071
[TBL] [Abstract][Full Text] [Related]
15. Tryptaminergic receptors in the bovine pulmonary vasculature: effects of ketanserin.
Ogunbiyi PO; Eyre P
Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):31-55. PubMed ID: 6328601
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the 5-HT receptor in rabbit saphenous vein exemplifies the problems of using exclusion criteria for receptor classification.
Martin GR; MacLennan SJ
Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):111-9. PubMed ID: 2234095
[TBL] [Abstract][Full Text] [Related]
17. Effects of selective 5-hydroxytryptamine-2 and nonselective 5-hydroxytryptamine antagonists on the differential-reinforcement-of-low-rate 72-second schedule.
Marek GJ; Seiden LS
J Pharmacol Exp Ther; 1988 Feb; 244(2):650-8. PubMed ID: 2894458
[TBL] [Abstract][Full Text] [Related]
18. Differential antagonism of the initial fast and secondary slow contractile responses of the rat isolated aorta to 5-hydroxytryptamine by mianserin and ketanserin.
Doggrell SA
J Auton Pharmacol; 1987 Jun; 7(2):157-64. PubMed ID: 3654683
[TBL] [Abstract][Full Text] [Related]
19. Endothelial relaxing 5-hydroxytryptamine receptors in the rat jugular vein: similarity with the 5-hydroxytryptamine1C receptor.
Bodelsson M; Törnebrandt K; Arneklo-Nobin B
J Pharmacol Exp Ther; 1993 Feb; 264(2):709-16. PubMed ID: 8437119
[TBL] [Abstract][Full Text] [Related]
20. Ketanserin causes surmountable antagonism of 5-hydroxytryptamine-induced contractions of large coronary arteries of dog.
Frenken M; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):301-3. PubMed ID: 3157065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
